These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 11363798)

  • 1. ACTG 152: new insights into pediatric antiretroviral therapy.
    Bowersox J
    NIAID AIDS Agenda; 1996 Mar; ():3. PubMed ID: 11363798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiretroviral combination treatment prolongs life in people with HIV/AIDS.
    Cooper EC
    AMFAR Rep; 1996 Jan; ():1-5. PubMed ID: 11363617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of pediatric study present new questions.
    Parks VE
    PI Perspect; 1995 May; (no 16):10. PubMed ID: 11362418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CPCRA 007: preliminary results of combination antiretroviral study.
    Randall P
    NIAID AIDS Agenda; 1996 Mar; ():2. PubMed ID: 11363796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; (3):CD002038. PubMed ID: 10908523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pediatric treatment update.
    Grubman S
    GMHC Treat Issues; 1996 Mar; 10(3):7-9. PubMed ID: 11363392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults.
    Darbyshire J; Foulkes M; Peto R; Duncan W; Babiker A; Collins R; Hughes M; Peto T; Walker A
    Cochrane Database Syst Rev; 2000; 2000(2):CD002038. PubMed ID: 10796851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapies improve outlook for children with HIV disease.
    NIAID AIDS Agenda; 1997 Aug; ():10. PubMed ID: 11364606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTG 175: new insights into treating patients with intermediate-stage HIV disease.
    Folkers G
    NIAID AIDS Agenda; 1995 Dec; ():4-5. PubMed ID: 11363352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AZT, ddI, and ddC combinations at FDA advisory hearing. Food and Drug Administration.
    James JS
    AIDS Treat News; 1996 Apr; (no 244):6. PubMed ID: 11363307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Researchers are rethinking role of AZT in drug therapy.
    AIDS Policy Law; 1995 Oct; 10(18):11. PubMed ID: 11362821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AZT and children.
    Treat Rev; 1995; (no 17):2. PubMed ID: 11362295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Now we know our AZTs, is it safe for kids and me?
    Parks VE
    Notes Undergr; 1995; (no 30):3, 8. PubMed ID: 11362407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits of combination therapy confirmed.
    Cheng B
    PI Perspect; 1995 Dec; (no 17):3-4. PubMed ID: 11363111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major pediatric study stopped early: combination treatment better.
    James JS
    AIDS Treat News; 1997 Jul; (No 274):5-6. PubMed ID: 11364462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AZT: pediatric study changed after worse monotherapy survival.
    AIDS Treat News; 1995 Feb; (no 217):8. PubMed ID: 11362307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dethroning AZT.
    Gilden D; Falkenberg J; Torres G
    GMHC Treat Issues; 1997 Feb; 11(2):10-3. PubMed ID: 11364106
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTG 175 and Delta.
    Torres G
    GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team.
    Englund JA; Baker CJ; Raskino C; McKinney RE; Petrie B; Fowler MG; Pearson D; Gershon A; McSherry GD; Abrams EJ; Schliozberg J; Sullivan JL
    N Engl J Med; 1997 Jun; 336(24):1704-12. PubMed ID: 9182213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.